A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly Compared With 25 mg Twice Weekly in Subjects With Ankylosing Spondylitis
收藏DataCite Commons2025-02-10 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006770/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare efficacy, pharmacokinetics, and safety of
investigational formulations of etanercept administered as 50 mg once weekly with 25 mg twice
weekly and placebo in patients with ankylosing spondylitis (AS).
提供机构：
Vivli
创建时间：
2021-04-02
